Hepanova
Gaithersburg
About Hepanova
Hepanova, Inc. is a clinical stage global pharmaceutical company founded in California, USA in 2014. The mission of Hepanova is to discover, develop and commercialize innovative therapeutics for chronic liver diseases with high unmet medical needs. Hepanova’s compelling pipelines include multiple R&D programs targeting non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibrosis, and hepatocellular carcinoma (HCC).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.2M
- Last round: Series Unknown (Apr 2023)
- Website: hepanova.com
- Phone: 240-702-0066
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hepanova-88371 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.